Syn2bio S.A. (WSE:S2B)
Poland
· Delayed Price · Currency is PLN 29.62
+0.62 (2.14%)
Last updated: Apr 29, 2026, 9:26 AM CET
Syn2bio Market Cap
Syn2bio has a market cap or net worth of 279.33 million as of April 29, 2026.
Market Cap
279.33M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
29.62
Market Cap Chart
Since April 16, 2026, Syn2bio's market cap has decreased from 311.63M to 279.33M, a decrease of -10.36%. That is a compound annual growth rate of -97.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 279.33M | -10.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Synthaverse | 242.74M |
| BIOTON | 358.91M |
| Bioceltix | 427.44M |
| Captor Therapeutics Spolka Akcyjna | 512.08M |
| Ryvu Therapeutics | 544.48M |
| Mabion | 132.85M |
| Molecure | 120.12M |
| NanoGroup | 108.28M |